Highlights Huadong Medicine Co., Ltd

Equities

000963

CNE0000011S1

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
33.76 ^CNY	+1.29%		+2.49%	-18.57%

25/04	Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/04	Huadong Medicine's 2023 Profit Jumps 14%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Huadong Medicine's 2023 Profit Jumps 14%	18/04	MT
Huadong Medicine Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
China's first biosimilar Ozempic drug applies for approval	03/04	RE
Huadong Medicine to Build 2 Billion Yuan Biopharma Innovation Center	09/02	MT
Huadong Medicine to Invest 2 Billion Yuan in Biopharma Innovation Center	09/02	MT
Huadong Medicine's 2023 Profit to Climb Up to 14.5%	01/02	MT
Huadong Medicine's Unit Gains Chinese Drug Regulator's Nod to Trial Sirolimus Oral Solution	06/12	MT
Huadong Medicine's Unit, Partners to Invest in Pharmaceutical Firm	14/11	CI
Huadong Medicine Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
Huadong Medicine's Unit Gets Nod to Test Weight Management Drug; Shares Up 3%	15/23/15	MT
Huadong Medicine’s H1 Profit Rises 7%; EPS, Revenue Miss Forecasts	16/23/16	MT
Huadong Medicine Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	15/23/15	CI
Arcutis Authorizes Huadong Medicine Unit to Manufacture, Commercialize Topical Roflumilast in China, Southeast Asia	10/23/10	MT
Huadong Medicine Unit Gets Nod to Conduct Trial on Tumor Drug	30/23/30	MT
Huadong Medicine Co., Ltd Implements Final Profit Distribution Plan of A Shares for 2022, Payable on 14 June 2023	09/23/09	CI
Huadong Medicine Gets US FDA's Nod for Trial of Diabetes Drug	17/23/17	MT
Huadong Medicine Co., Ltd Approves Cash Dividend for 2022	10/23/10	CI
Huadong Medicine’s Q1 Profit Rises 7% as Revenue Jumps 13%	21/23/21	MT
Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	20/23/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Huadong Medicine Co., Ltd

Equities

000963

CNE0000011S1

Highlights

Filters